• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在随机混合人群中疫苗接种效果的衡量指标。

Measures of the effects of vaccination in a randomly mixing population.

作者信息

Haber M, Longini I M, Halloran M E

机构信息

Department of Epidemiology and Biostatistics, Emory University, Atlanta, Georgia 30329.

出版信息

Int J Epidemiol. 1991 Mar;20(1):300-10. doi: 10.1093/ije/20.1.300.

DOI:10.1093/ije/20.1.300
PMID:2066239
Abstract

Vaccine efficacy in the field is often derived from the relative attack rates in the vaccinated and unvaccinated after an outbreak. In this paper, vaccine efficacy is defined in terms of the probability that the infectious agent is transmitted from an infected to a susceptible person, and a method for estimating it from the usual attack rate data is given. We explore two mechanisms of vaccine action defined by Smith et al, but include an underlying dynamic epidemic model of an acute directly transmitted disease. We show analytically that under the model in which the vaccine mechanism reduces the probability of infection given a certain exposure, vaccine efficacy based on the relative attack rates underestimates the protective effect of the vaccine based on the relative transmission probabilities. Under the other model in which the vaccine mechanism offers complete protection to a certain proportion of those vaccinated, and no protection to the other vaccinated proportion, the vaccine efficacy based on the relative attack rates will equal that based on the transmission probabilities. Parameters for the effectiveness of a vaccination programme are defined in terms of the direct and indirect benefit to a single person as well as the total and average benefit to the entire population, and derived from the dynamic model for an outbreak of an acute directly transmitted disease. These effects can also be estimated without an actual separate unvaccinated population, independent of assumptions about the vaccine mechanism. The variation of these measures as functions of the fraction of vaccinated people in the population is explored numerically.

摘要

疫苗在实际应用中的效力通常源于疫情爆发后接种疫苗者和未接种疫苗者的相对发病率。本文根据感染源从感染者传播至易感者的概率来定义疫苗效力,并给出了一种根据常见发病率数据估算疫苗效力的方法。我们探讨了史密斯等人定义的两种疫苗作用机制,但纳入了一种急性直接传播疾病的潜在动态流行模型。我们通过分析表明,在疫苗机制降低给定暴露情况下感染概率的模型中,基于相对发病率的疫苗效力低估了基于相对传播概率的疫苗保护效果。在另一种模型中,疫苗机制为一定比例的接种者提供完全保护,而对另一部分接种者不提供保护,基于相对发病率的疫苗效力将等于基于传播概率的疫苗效力。疫苗接种计划有效性的参数是根据对个体的直接和间接益处以及对整个人口的总体和平均益处来定义的,并从急性直接传播疾病爆发的动态模型中推导得出。这些影响也可以在没有实际单独的未接种人群的情况下进行估算,且与关于疫苗机制的假设无关。我们通过数值方法探讨了这些指标随人群中接种者比例的变化情况。

相似文献

1
Measures of the effects of vaccination in a randomly mixing population.在随机混合人群中疫苗接种效果的衡量指标。
Int J Epidemiol. 1991 Mar;20(1):300-10. doi: 10.1093/ije/20.1.300.
2
[Measures of the effect of vaccination in an outbreak of measles].
Gac Sanit. 1993 Jul-Aug;7(37):164-8. doi: 10.1016/s0213-9111(93)71148-6.
3
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?一剂水痘疫苗无法预防学校爆发疫情:是时候接种第二剂了吗?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
4
Estimation of vaccine efficacy in outbreaks of acute infectious diseases.急性传染病暴发中疫苗效力的评估。
Stat Med. 1991 Oct;10(10):1573-84. doi: 10.1002/sim.4780101009.
5
Estimation of the direct and indirect effects of vaccination.疫苗接种直接和间接效果的评估。
Stat Med. 1999 Aug 30;18(16):2101-9. doi: 10.1002/(sici)1097-0258(19990830)18:16<2101::aid-sim178>3.0.co;2-6.
6
Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission.接种疫苗和未接种疫苗人群混合对传染病动力学的影响:对 SARS-CoV-2 传播的启示。
CMAJ. 2022 Apr 25;194(16):E573-E580. doi: 10.1503/cmaj.212105.
7
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.在根据多个群体的易感性和传染性估计疫苗效力时的最佳疫苗试验设计。
Stat Med. 1998 May 30;17(10):1121-36. doi: 10.1002/(sici)1097-0258(19980530)17:10<1121::aid-sim824>3.0.co;2-e.
8
Estimation of vaccine efficacy and the vaccination threshold.疫苗效力及接种阈值的估算
Stat Med. 2007 Oct 30;26(24):4475-88. doi: 10.1002/sim.2874.
9
Outbreak of measles in a highly vaccinated secondary school population.在一个高疫苗接种率的中学人群中爆发麻疹。
CMAJ. 1996 Nov 15;155(10):1407-13.
10
[Assessing the effectiveness of vaccination programs].[评估疫苗接种计划的有效性]
Gac Sanit. 2011 Jun;25 Suppl 1:49-55. doi: 10.1016/S0213-9111(11)70008-5.

引用本文的文献

1
Indirect protection from rotavirus vaccines: a systematic review.轮状病毒疫苗的间接保护作用:系统评价。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):789-795. doi: 10.1080/14760584.2024.2395534. Epub 2024 Sep 1.
2
Mathematical modeling for estimating influenza vaccine efficacy: A case study of the Valencian Community, Spain.用于估计流感疫苗效力的数学建模:以西班牙巴伦西亚自治区为例的研究。
Infect Dis Model. 2024 Apr 24;9(3):744-762. doi: 10.1016/j.idm.2024.04.006. eCollection 2024 Sep.
3
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo.
评估 2022 年初奥密克戎变异株(B.1.1.529)流行期间的 COVID-19 疫苗接种计划,东京。
BMC Infect Dis. 2023 Oct 31;23(1):748. doi: 10.1186/s12879-023-08748-1.
4
Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number.利用反事实繁殖数评估 2021 年日本的 COVID-19 疫苗接种计划。
Sci Rep. 2023 Oct 18;13(1):17762. doi: 10.1038/s41598-023-44942-6.
5
Transporting monovalent rotavirus vaccine efficacy estimates to an external target population: a secondary analysis of data from a randomised controlled trial in Malawi.将单价轮状病毒疫苗效力估计值外推至目标人群:马拉维一项随机对照试验数据的二次分析。
Epidemiol Infect. 2023 Feb 27;151:e49. doi: 10.1017/S0950268823000286.
6
A compelling demonstration of why traditional statistical regression models cannot be used to identify risk factors from case data on infectious diseases: a simulation study.有力地证明了为什么传统的统计回归模型不能用于从传染病病例数据中识别风险因素:一项模拟研究。
BMC Med Res Methodol. 2022 May 20;22(1):146. doi: 10.1186/s12874-022-01565-1.
7
Oral Cholera Vaccine Efficacy and Effectiveness.口服霍乱疫苗的效力和效果
Vaccines (Basel). 2021 Dec 15;9(12):1482. doi: 10.3390/vaccines9121482.
8
Vaccine and vaccination as a part of human life: In view of COVID-19.疫苗和接种疫苗作为人类生活的一部分:以 COVID-19 为例。
Biotechnol J. 2022 Jan;17(1):e2100188. doi: 10.1002/biot.202100188. Epub 2021 Nov 21.
9
Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach.侵袭性肺炎球菌病结合疫苗在芬兰的影响和效果-一种建模方法。
Hum Vaccin Immunother. 2021 Jun 3;17(6):1834-1843. doi: 10.1080/21645515.2020.1836918. Epub 2020 Dec 17.
10
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).疫苗的获益-风险评估。第二部分:应用于疫苗的定量获益-风险模型报告的统一标准建议(BRIVAC)。
Drug Saf. 2020 Nov;43(11):1105-1120. doi: 10.1007/s40264-020-00982-9.